Podcast

Improving the Healthcare System for African American Patients

Author(s):

Featuring insights from Dr. Raj Chovatiya, Dr. Karan Lal and more on what can be done to promote inclusivity and improved care for patients with skin of color.

At HCPLive, we’ve had the incredible privilege of speaking with doctors from a variety of different clinical fields as well as different cultural, racial, and ethnic backgrounds. Without their dedication, insights, and generosity, the health care system and the world at large would be at a loss.

Even publications such as our own benefit from their work in a myriad of ways. In this episode of DocTalk, we offer listeners a glimpse of some of the most memorable and insightful interviews regarding skin of color, health inequities, and how clinical fields such as dermatology and rheumatology can improve care for Black and Brown patients and physicians alike.

This episode’s featured segments include:

  • Raj Chovatiya, MD, PhD, on diversifying clinical trials and other studies
  • Karan Lal, DO, MS, FAAD, on scientific literature dedicated to skin of color
  • Megha Shankar, MD, on avoiding labeling certain skin types as normal/abnormal
  • Ehizogie Edigin, MD, on the prevalence of systemic lupus erythematosus flares in African Americans
  • Titilope Fasipe, MD, PhD, on acknowledging deficiencies in sickle-cell care for African American patients
Related Videos
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
How to Manage Aspirin-Exacerbated Respiratory Disease
Diabetes Dialogue: Tirzepatide’s Long-Term Obesity Data | Image Credit: HCPLive
Diabetes Dialogue: Latest Updates on Semaglutide Shortage, Data | Image Credit: HCPLive
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.